Clinical trial
The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants
NCT00551642 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants
- Lead sponsor
- Mallinckrodt
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 29, 2005
- Completion date
- July 17, 2015
- Enrollment
- 800 (actual)
- Sites
- 35
Conditions
As the registry lists them; a condition with its own page is linked.
lung disease